Repositorio de Universidad Autónoma de Chile.
metadata only
Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives
Parkinson’s disease is a neurodegenerative disorder accompanied by depletion of dopamine and loss of dopaminergic neurons in the brain that is believed to be responsible for the motor and non-motor symptoms in this disease. The main drug prescribed for Parkinsonian patients is l-dopa, which can be c
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Managing Changes in Life After Deep Brain Stimulation for Parkinson's Disease#884247
- Tolerability, Safety and Efficacy of Vortioxetine#1125453
- TRANSCRANIAL DIRECT CURRENT STIMULATION (t-DCS) AS ADD-ON TO NEUROREHABILITATION OF PISA SYNDROME IN PARKINSON DISEASE#871742
- Study of Antidepressants in Parkinson's Disease#870228
- Dopamine Effect on Inhibitory Control#1152832
Record · ID 935861
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive